LVTX logo

LAVA Therapeutics NV (LVTX)

Profile

Full Name

LAVA Therapeutics N.V.

Ticker Symbol

LVTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Netherlands

IPO

March 26, 2021

Indexes

Not included

Website

http://www.lavatherapeutics.com

Employees

34

Key Details

Price

$1.10(+0.92%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$11.98M(+77.01% YoY)

Annual EPS

-$0.94(+40.13% YoY)

PE ratio

-

Next earnings date

May 21, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.10
LVTX price is $1.10

30-Day Relative Volume

1.63
LVTX 30-day relative volume is 1.63

Price Performance

Price Today change

+0.92%
LVTX price is up +0.92% today

Price YTD change

+15.67%
LVTX price is up +15.67% since January 1st

Price 1-year change

-64.86%
LVTX price is down -64.86% year-on-year

Price 3-year change

-74%
LVTX price is down -74% over the past 3 years

Price Range

Price All-time high

$17.20
LVTX price is currently -93.60% below its historical high of $17.20

Price 3-year low

$0.85
LVTX price is currently +29.41% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$28.94M
LVTX market capitalization is $28.94 million

Market cap 3-year change

-73.46%
LVTX market capitalization is down -73.46% over the past 3 years

Market cap All-time high

$401.83M
LVTX market capitalization is currently -92.80% below its historical high of $401.83 million

Market cap sector rank

31.39%
LVTX market capitalization is higher than 31.39% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.05%
LVTX shares outstanding is up +0.05% year-on-year

Shares Outstanding 3-Year Change

+2.06%
LVTX shares outstanding is up +2.06% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.41
LVTX beta is 0.41

200-day SMA

$1.50
LVTX price is currently -26.74% below its 200-day simple moving average

50-day SMA

$1.17
LVTX price is currently -5.88% below its 50-day simple moving average

RSI

32.79
LVTX 14-day relative strength index is 32.79

Volume

1.63
LVTX 30-day relative volume is 1.63

ATR

$0.07
LVTX average true range is $0.07

10-day Historical Volatility

36.87%
LVTX 10-day historical volatility is 36.87%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$11.98M
LVTX annual revenue is $11.98 million

Revenue Analysts estimate

-
LVTX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+77.01%
LVTX annual revenue is up +77.01% year-on-year

Revenue Sector rank

30.57%
LVTX annual revenue is higher than 30.57% of companies in Healthcare sector

EPS

EPS

-$0.94
LVTX annual earnings per share is -$0.94

EPS Analysts estimate

-$1.44
LVTX annual earnings per share is currently -34.52% lower than the consensus analysts' forecast

EPS 1-year change

+40.13%
LVTX annual earnings per share is up +40.13% year-on-year

EPS Sector rank

58.13%
LVTX annual earnings per share is higher than 58.13% of companies in Healthcare sector

Profit

Gross profit

$11.98M
LVTX annual gross profit is $11.98 million

Gross margin

-
LVTX annual gross profit margin value is unknown

Operating profit

-$29.69M
LVTX annual operating income is -$29.69 million

Operating margin

-247.81%
LVTX annual operating profit margin is -247.81%

Net income

-$25.11M
LVTX annual net profit is -$25.11 million

Net margin

-209.60%
LVTX annual net profit margin is -209.60%

Expenses

Total expenses

$41.67M
LVTX annual total expenses is $41.67 million

Operating expenses

$41.67M
LVTX annual total operating expenses is $41.67 million

Cost of goods sold

-
LVTX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$13.22M
LVTX annual SGA is $13.22 million

Depreciation and amortization

$467.00K
LVTX annual depreciation & amortization is $467.00 thousand

Interest expense

$515.00K
LVTX annual interest expense is $515.00 thousand

Income tax

$630.00K
LVTX annual income tax is $630.00 thousand

EBIT & EBITDA

EBIT

-$23.97M
LVTX annual earnings before interest & taxes is -$23.97 million

EBITDA

-$23.50M
LVTX annual EBITDA is -$23.50 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$80.83M
LVTX annual total assets is $80.83 million

Non current assets

$1.53M
LVTX annual long term assets is $1.53 million

Current assets

$79.30M
LVTX annual total current assets is $79.30 million

Cash and cash equivalents

$35.02M
LVTX annual cash & cash equivalents is $35.02 million

Accounts receivable

-
LVTX annual accounts receivable value is unknown

Inventory

-
LVTX annual inventory value is unknown

Liabilities

Total liabilities

$53.09M
LVTX annual total liabilities is $53.09 million

Long term liabilities

$35.08M
LVTX annual total long term liabilities is $35.08 million

Current liabilities

$18.01M
LVTX annual total current liabilities is $18.01 million

Accounts payable

$2.72M
LVTX annual accounts payable is $2.72 million

Debt

Total debt

$5.28M
LVTX annual total debt is $5.28 million

Total debt 1-year change

-13.6%
LVTX annual total debt is down -13.6% year-on-year

Long term debt

$80.00K
LVTX annual long term debt is $80.00 thousand

Short term debt

$5.20M
LVTX annual short term debt is $5.20 million

Equity & Capital

Shareholders equity

$27.75M
LVTX annual stockholders equity is $27.75 million

Book value

$27.75M
LVTX annual book value is $27.75 million

Retained earnings

-$174.97M
LVTX annual retained earnings is -$174.97 million

Working capital

$61.29M
LVTX annual working capital is $61.29 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$19.54M
LVTX annual cash flow from operations is -$19.54 million

Cash from operations 1-year change

+51.48%
LVTX annual cash flow from operations is up +51.48% year-on-year

Cash from investing

$12.47M
LVTX annual cash flow from investing activities is $12.47 million

Cash from investing 1-year change

+170.74%
LVTX annual cash flow from investing activities is up +170.74% year-on-year

Cash from financing

-$569.00K
LVTX annual cash flow from financing activities is -$569.00 thousand

Cash from financing 1-year change

-100%
LVTX annual cash flow from financing activities is down -100% year-on-year

CAPEX

CAPEX

$23.00K
LVTX annual capital expenditures is $23.00 thousand

CAPEX 1-year change

-96.85%
LVTX annual capital expenditures is down -96.85% year-on-year

Free Cash Flow

Free cash flow

-$19.57M
LVTX annual free cash flow is -$19.57 million

Free cash flow 1-year change

+52.29%
LVTX annual free cash flow is up +52.29% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
LVTX annual gross profit margin value is unknown

Operating margin

-247.81%
LVTX annual operating profit margin is -247.81%

Net margin

-209.60%
LVTX annual net profit margin is -209.60%

ROA & ROE

ROA

-27.52%
LVTX annual return on assets is -27.52%

ROE

-63.49%
LVTX annual return on equity is -63.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LVTX price to earnings ratio value is unknown

PE ratio Sector rank

-
LVTX price to earnings ratio is unknown

PB Ratio

PB ratio

1.04
LVTX price to book ratio is 1.04

PB ratio Sector rank

44.82%
LVTX price to book ratio is higher than 44.82% of companies in Healthcare sector

PS Ratio

PS ratio

2.41
LVTX price to sales ratio is 2.41

PS ratio Sector rank

45.9%
LVTX price to sales ratio is higher than 45.9% of companies in Healthcare sector

Enterprise value

Enterprise value

-$798.17K
LVTX enterprise value is -$798.17 thousand

Enterprise value Sector rank

10.9%
LVTX enterprise value is higher than 10.9% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.03
LVTX EV/EBITDA is 0.03

EV/EBITDA Sector rank

65.42%
LVTX EV/EBITDA is higher than 65.42% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.40
LVTX annual current ratio is 4.40

Quick ratio

-
LVTX annual quick ratio value is unknown

Leverage

Debt to equity

0.18
LVTX annual debt to equity ratio is 0.18

Interest coverage ratio

-46.54
LVTX annual interest coverage ratio is -46.54

Risk & Stability

Piotroski F-Score

-
LVTX piotroski f-score value is unknown

Altman Z-Score

-2.62
LVTX altman z-score is -2.62

Analyst ratings

Recent major analysts updates

Mar 31, 25 HC Wainwright & Co.
Neutral
Feb 27, 25 HC Wainwright & Co.
Neutral
Dec 20, 24 HC Wainwright & Co.
Buy
Dec 12, 24 Leerink Partners
Market Perform
Dec 11, 24 JMP Securities
Market Perform
Aug 21, 24 JMP Securities
Market Outperform
Jun 28, 24 HC Wainwright & Co.
Buy
Mar 21, 24 HC Wainwright & Co.
Buy
Dec 22, 21 SVB Leerink
Outperform
Nov 16, 21 SVB Leerink
Outperform

Institutional Ownership

Similar stocks

INTS logo
Intensity Therapeutics (INTS)
GDTC logo
CytoMed Therapeutics Limited (GDTC)
KZR logo
Kezar Life Sciences (KZR)
ALLK logo
Allakos (ALLK)
BRNS logo
Barinthus Biotherapeutics (BRNS)
RNXT logo
RenovoRx (RNXT)
Cadrenal Therapeutics (CVKD)
FGEN logo
FibroGen (FGEN)
CLGN logo
CollPlant Biotechnologies (CLGN)
  • What is the ticker symbol for LAVA Therapeutics NV?
  • Does LAVA Therapeutics NV pay dividends?
  • What sector is LAVA Therapeutics NV in?
  • What industry is LAVA Therapeutics NV in?
  • What country is LAVA Therapeutics NV based in?
  • When did LAVA Therapeutics NV go public?
  • Is LAVA Therapeutics NV in the S&P 500?
  • Is LAVA Therapeutics NV in the NASDAQ 100?
  • Is LAVA Therapeutics NV in the Dow Jones?
  • When was LAVA Therapeutics NV's last earnings report?
  • When does LAVA Therapeutics NV report earnings?
  • Should I buy LAVA Therapeutics NV stock now?

What is the ticker symbol for LAVA Therapeutics NV?

The ticker symbol for LAVA Therapeutics NV is NASDAQ:LVTX

Does LAVA Therapeutics NV pay dividends?

No, LAVA Therapeutics NV does not pay dividends

What sector is LAVA Therapeutics NV in?

LAVA Therapeutics NV is in the Healthcare sector

What industry is LAVA Therapeutics NV in?

LAVA Therapeutics NV is in the Biotechnology industry

What country is LAVA Therapeutics NV based in?

LAVA Therapeutics NV is headquartered in Netherlands

When did LAVA Therapeutics NV go public?

LAVA Therapeutics NV's initial public offering (IPO) was on March 26, 2021

Is LAVA Therapeutics NV in the S&P 500?

No, LAVA Therapeutics NV is not included in the S&P 500 index

Is LAVA Therapeutics NV in the NASDAQ 100?

No, LAVA Therapeutics NV is not included in the NASDAQ 100 index

Is LAVA Therapeutics NV in the Dow Jones?

No, LAVA Therapeutics NV is not included in the Dow Jones index

When was LAVA Therapeutics NV's last earnings report?

LAVA Therapeutics NV's most recent earnings report was on Mar 28, 2025

When does LAVA Therapeutics NV report earnings?

The next expected earnings date for LAVA Therapeutics NV is May 21, 2025

Should I buy LAVA Therapeutics NV stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page